Wednesday, June 5, 2013

DisabilityCare Australia: First the euphoria, then the questions to be ...

Posted by christinefjohnston in Education Policy and Politics, Social Justice and Equity through Education.
Tags: children with special needs, disability, early childhood intervention
trackback

From Assoc. Prof.? Christine Johnston

I am not embarrassed to admit that, like the Prime Minister, I was teary-eyed on seeing the legislation for the establishment of DisabilityCare pass through the parliament with bi-partisan support. I had not expected it would happen so quickly and so decisively. But that very speed brings with it some questions and possible dangers which are worth thinking about as the euphoria settles and the launch begins.

It is a clich?, but nonetheless true, that the introduction of DisabilityCare Australia is a game changer for all those who have a disability (or who will acquire a disability). At its centre is recognition of the life-long impact which a disability has on individuals and those around them; their families, friends and colleagues. But it is more than that. It is a fundamental acknowledgement of the rights of those with disabilities to participate in the community and to have available the supports necessary for them to do so. Most important is that it seeks to place control in the hands of the user. Individualised funding means that services are targeted and chosen by the person with a disability or, where appropriate, by their advocate. It will, then, essentially provide a system where the individual purchases the services they want and need. This will have profound consequences both for the individual and, potentially, for the services that currently exist.

My particular interest is in early childhood intervention and how individualised funding will work for families who have a young child with a disability. Imagine that your child has just been identified as having a disability. You know little about your child?s disability and even less about what interventions might be useful. However, you now have funding available to you to buy services for your child and family. On what basis do you do this? How do you learn about your child?s disability? And, just as importantly, how do you decide what interventions will be most useful at this time in your child?s life?

These questions are not new and they are not ones that arise because of individualised funding: they exist now and are experienced by all families at the time of identification and/or diagnosis. Indeed, it can be argued that the experience of adults learning that they have an acquired disability will be similar. The difference is that families now engaged with early childhood intervention services generally have access to professionals who can enable them to make these decisions.

Early childhood intervention is predicated on the philosophy of family-centred practice (Dunst, 2004; Dunst & Trivette, 2005; Moore, 2010). Rather too simply put its basic tenets are these: parents are the experts on their family and child, services should be coordinated and family-driven, and disability affects not only the child but the family. An individual funding model therefore fits well into this philosophy. However, there are some provisos.

In a family-centred model, the approach to intervention should largely be one that utilises natural learning environments and opportunities (Dunst & Bruder, 2002). Furthermore, the approach to service delivery should ensure that the child and family are not overwhelmed by the number of professionals with whom they have to deal: a transdisciplinary model which utilises a key worker to coordinate services and advocate for the child and family is therefore seen as optimal (Drennan, Wagner, & Rosenbaum, 2005). Families can, of course take on this role if they wish. What is unclear at present is whether case managers skilled in early childhood intervention practice will be available to families who have a young child with a disability under the new model and how their services will be paid for.

This is a crucial consideration. Anecdotal evidence from parents who have been using individualised funding suggests that they may take on this role themselves since to bring the professionals (generally therapists) together will be an additional cost and subtract from the monies available to them for direct intervention for their child. For some families this is an appropriate solution, for others it may be yet another pressure in an already stressful situation.

Moreover, in a model where the family purchases services how do they make decisions about what intervention approach should be taken and who they should engage to do it? The importance of evidence-based practice, not just in early childhood intervention, but in medicine and education is well accepted. ?Considerable thought needs to be given to what information and supports families need in order to be able to judge the credibility of claims for various approaches to intervention and the validity of information posted on websites. The provision of a list of approved providers by DisabilityCare will go some considerable way to solving this problem but it will not solve it completely. Families need access to experienced and skilled early childhood intervention professionals who can assist them to make sense of the plethora of information and possibilities.

My conversations so far with families who have a young child with a disability have led me to the conclusion that they, at least, are assuming that individualised funding will occur alongside their access to dedicated, multi-disciplinary early childhood intervention services. They have some justification in this assumption as this is what occurs with the Better Start and Helping Children with Autism funding. Whether this will continue seems far from clear at present. Will these services also be fully dependent on attracting funds directly from families and, if they do, will families be prepared or able to pay for coordination of their services and assistance with choice?

My other concern relates to the early childhood intervention services themselves. In those services we have a wealth of experience, talent and expertise. And, we have a means of inducting new therapists, educators and other allied health staff through their being mentored by expert staff. We cannot afford to lose this. Ways must be found of utilising this knowledge; the role of early childhood services must be guaranteed if we are not to return to earlier approaches which are far from family-centred.

DisabilityCare offers extraordinary opportunities but, as suggested, there are inherent questions that must be addressed. The launch of the program in July will provide the vehicle for robust discussion and evaluation. We must take up that opportunity and work to make DisabilityCare the best it can.

References

Drennan, A., Wagner, T. & Rosenbaum, P. (2005). The ?Key Worker? Model of Service Delivery. Keeping Current #1-2005. Hamilton, Ontario: CanChild Centre for Disability Research.

http://bluewirecs.tzo.com/canchild/kc/KC2005-1.pdf

?Dunst, C.J. (2004). An integrated framework for practicing early childhood intervention and family support. Perspectives in Education, 22 (2) 1-16.

Dunst, C.J. & Bruder, M.B. (2002). Valued outcomes of service coordination, early intervention, and natural environments. Exceptional Children, 68 (3), 361-375.

Dunst, C.J. & Trivette, C.M. (2005). Measuring and evaluating family support program quality. Asheville, North Carolina: Winterberry Press.

Moore, T. (2010). Revised Literature review for the DEECD Early Childhood Intervention Reform Project. Melbourne: CCCH.

Christine Johnston is Director, Engagement and International in the School of Education at the University of Western Sydney

Like this:

Like Loading...

Source: http://learning21c.wordpress.com/2013/06/04/disabilitycare-australia-first-the-euphoria-then-the-questions-to-be-solved/

andrew shaw hologram pulitzer prize winners nfl 2012 schedule gmail down tim lincecum ryan oneal

Mailbox co-founder hints at desktop app

Mailbox CEO hints at desktop app

Although Mailbox can play nicely with Gmail on iOS, one of the bigger gaps in its resume is the lack of desktop availability. During a keynote at the DEMO Europe conference, CEO Gentry Underwood hinted that might change soon, saying that a desktop app "is something we have to do in order to stay competitive," and that "it's on our roadmap." The Mailbox app -- which promises "inbox zero" -- is currently limited to iOS devices and Gmail, whereas Dropbox, which recently purchased it for a rumored $100 million, is available on virtually all platforms. With the need to add Android and desktop clients, not to mention support for other email services like Outlook, Mailbox's roadmap is now bumper-to-bumper -- we'll just have to wait and see which drops first.

Filed under: , ,

Comments

Via: TNW

Source: Demo Europe

Source: http://www.engadget.com/2013/06/04/mailbox-co-founder-hints-at-desktop-app/?utm_medium=feed&utm_source=Feed_Classic&utm_campaign=Engadget

Snoop Lion London 2012 Table Tennis badminton Dominique Dawes Gabby Olympic Gymnast Robyn Lawley Gore Vidal

Samsung Galaxy S 4 mini, GT-S7272 reach the FCC

Samsung Galaxy S 4 mini, GTS7272 reach the FCC

Well, that was fast. Samsung only just unveiled the Galaxy S 4 mini last week, and today the device is swinging through the FCC as the GT-i9195. Sadly, this particular version of the mini isn't likely to reach the US -- its LTE only works in South Korea and a handful of other distant countries. We're almost more interested in a second device, the GT-S7272, which is reaching the FCC at the same time. While this too won't hit the US when it doesn't even support American 3G frequencies, its model name is commonly (if unofficially) associated with a dual-SIM version of the unannounced Galaxy Ace 3, which may have both Android 4.2 and a WVGA screen. We'll keep our eyes peeled for versions of either smartphone that are friendlier to North American shores.

Filed under: , ,

Comments

Source: FCC (1), (2)

Source: http://www.engadget.com/2013/06/04/samsung-galaxy-s-4-mini-gt-s7272-reach-the-fcc/?utm_medium=feed&utm_source=Feed_Classic&utm_campaign=Engadget

mike dantoni bulls heat goldman sachs brandon carr knicks coach encyclopedia britannica white lion

Saturday, June 1, 2013

Liberty Reserve's money laundering spotted in 2009

(AP) ? Costa Rican officials say the currency transfer firm Liberty Reserve first raised red flags in the Central American country in 2009 when authorities detected money laundering activities.

Anti-drug Institute Deputy Director Bernardita Marin says bank officials reported suspicious activities in 2009 and in 2010 to the government's Financial Intelligence Unit, which began investigating.

The investigation was turned over to prosecutors in 2011, the same year the United States informed Costa Rica about Liberty Reserve's criminal activities.

Marin says that Liberty Reserve moved about $100 million through Costa Rican banks.

Liberty Reserve's founder Arthur Budovsky was arrested Friday at a Madrid airport while trying to return home to Costa Rica.

U.S. federal prosecutors charged seven people Tuesday, including Budvosky, with running an underworld bank that handled $6 billion around the world.

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/f70471f764144b2fab526d39972d37b3/Article_2013-05-31-LT-Costa-Rica-Digital-Currency/id-abc218c266b749a084cb51cb0f9fccfc

uss enterprise white house easter egg roll 2012 andy cohen andy cohen mozambique oosthuizen

Friday, May 31, 2013

Can Humans Really Feel Hot and Cold?

If you compare the feeling of touching a piece of metal versus a piece of paper, the metal will always seem cooler, even if both objects are actually the same temperature. So what gives? It turns out that what we're really feeling as cold when we touch something is actually an object's increased ability to conduct thermal energy away from our skin.

Temperature is technically just a measurement of how much atoms and molecules in a given object are moving. The more movement, the hotter it feels. And since metal is a good conductor, it actually pulls thermal energy away from our skin when touched, causing our thermo-receptive nerves to interpret the loss of energy as the object being cold. So maybe meteorologists should start providing forecasts based on how quickly our bodies will gain and lose thermal energy throughout the day, instead of it being hot or cold. Or, maybe not.

Source: http://gizmodo.com/can-humans-really-feel-hot-and-cold-510473773

angelina jolie leg daytona artie lange nascar daytona 2012 kasey kahne angelina jolie right leg saving face

Alterra captures the Capitol Square with more than coffee - Isthmus ...

When you order a coffee from the coffee bar portion of Alterra, where fresh cups are produced one at a time like all the cool coffeehouses do it now, you sort of hover near the bar and wait. When you order food and choose to sit at a table outside, your food is brought to you by table number. But when you do both? Well, you figure it out, because I had to ask. (There's no good way.)

The newest location for Milwaukee-based Alterra is on the Square in Tenney Plaza, and it wants to be your destination for almost everything downtown. Brewed coffee, coffee beans, Wi-Fi, smoothies, breakfast, lunch, dessert and even a beer after work ? yes, Alterra aims for all of these. But its success varies at achieving the diverse goals.

For a hot cup of coffee, the aforementioned coffee bar offers pour-overs of a small selection of beans and assures a fresh, rich cup every time ? even if you have to wait a little longer than for a standard brew. The dark, rich Maximilian roast is a personal favorite, but if you prefer a lighter roast, Del Sol is juicy and invigorating. Iced coffee, however, lacks the smooth, full body of the best cold-processed versions in town. (4 & 20, Madison Sourdough and Crema Cafe come to mind.)

Bakery is another strong suit, with house-made breads and pastries coming fresh from the Bayview location daily. A lemon-blueberry scone featured strong flavors of both, topped with crystals of sugar for a pleasant crunch. Closer to Cinco de Mayo, a cinnamon-guajillo chile brownie with a layer of dulce de leche was as sweet and decadent as you'd imagine, with the pepper bringing only the flirtation of heat.

Unfortunately, a slick-looking soft pretzel is inexcusably chewy, even after being warmed up, and bland besides. The chocolate croissant is equally featureless.

There ends the purview of the average coffee shop ? oh, but yes, the Wi-Fi is also good, if the number of laptops is any indication. The rest of the day's service is a mix of bonus points and overreach.

Bonus points: the biscuits. They're massive, they're good ? maybe a little dry ? and they serve as a fine vessel for breakfast sandwiches. Here's a puzzler, though: If the bacon biscuit is essentially the cheesy biscuit plus bacon, why do they cost the same? Either way, be careful; it comes out steaming hot. Take your time and figure out that bacon math.

Burritos are all over the menu at Alterra, and this is the disappointing overreach. Combinations like jerk chicken and potato, or eggs and sausage (they are specials, but tend to stick around for a while), sound great. But the latter was an indistinct agglomeration, and the former was too distinct by half, with the jerk chicken and potato split down the middle like boys and girls at a junior high dance.

Alterra's burritos are just not very good. Maybe a step above something fast-casual like Panera, with the character pressed and toasted right out of them.

A decent pesto mozzarella sandwich arrives with gooey, molten cheese in a bun the size and shape of a long john that envelops the fillings; call it a Haute Pocket. It's better by far than the tomato basil turkey sandwich, featuring both an odd (but flavorful) basil lemon cream cheese and melted provolone. This one is unpleasantly slippery, overloaded with moisture and goo.

All the unfulfilled promise of lunch is reversed with the smoothie, a vastly overexposed segment of the drink market that turns unexpectedly into something worth ordering in Alterra's hands. The mango peach ginger version tastes of all three, with recognizable yogurt notes underneath. I'd order one of these over most of Jamba Juice's menu.

And for something with a little more oomph, there's always the Cortado Imperial Coffee Stout, brewed with Alterra's beans by Madison's own One Barrel Brewing. It's a lovely beer, with no sharp edges and plenty of smooth coffee flavor. One barista told me she's actually seen someone order one at seven in the morning. There's also a pale ale that apparently sells almost as well, but I don't see how that's possible with something as charming as the Cortado on the menu.

As an all-occasion cafe, Alterra's successes can easily get lost in the hubbub. The best bites I took there were in its first few days, before I was officially reviewing it: a silky smoked salmon sandwich with capers and cream cheese, and a falafel burger with a thin raita-esque sauce. I'd say I liked Alterra before it was cool, but it's been a hotspot since the day it opened, and so popular you might not even notice its flaws.

Source: http://www.thedailypage.com/isthmus/article.php?article=40051

Cullen Finnerty LA Kings maria menounos Mermaids New Evidence Raspberry Pi memorial day stacy keibler

GSK bets on chimp virus with $321 million vaccines buy

By Ben Hirschler

LONDON (Reuters) - GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring Swiss-based Okairos for 250 million euros (321 million U.S. dollars) - the latest bolt-on biotech buy by a big drugmaker.

Britain's largest pharmaceuticals group said on Wednesday that the privately owned company's know-how was expected to play an important role in GSK's development of vaccines to both prevent and treat diseases.

Okairos was spun out from Merck & Co in 2007 and has laboratories in Rome and Naples, with headquarters in Basel.

It specializes in making vaccines that target the immune system's CD8 T-cells - an approach that could yield preventative vaccines against several intractable infectious diseases, including hepatitis C, and also help fight cancer.

It does this by delivering genetic material using deactivated chimpanzee-derived adenoviruses that produce a very strong response against target diseases.

Adenoviruses, which cause the common cold, have long been studied as a useful delivery vehicle for genetic material - but they are so common that many people already have antibodies against them.

Chimp viruses, which are not so easily detected by the body's immune system, have an advantage since they can operate for longer and therefore elicit a powerful T-cell response.

The Okairos technology has already been tested in clinical studies involving more than 700 subjects, including mid-stage Phase II programs in hepatitis C and malaria.

A hepatitis C shot could be particularly promising commercially, since there is currently no vaccine and treating the condition with drugs has become a multibillion-dollar business.

Okairos also has early stage products for diseases such as respiratory syncytial virus (RSV), tuberculosis, ebola and HIV.

NEW GENERATION OF VACCINES

The real attraction lies less in individual products than in the company's technology platform, which GSK hopes to exploit within its own vaccine development programs.

As such, the deal represents a long-term investment in a promising new scientific area, rather than one that will yield immediate financial rewards.

Christophe Weber, GSK's head of vaccines, said the acquisition of Okairos was "expected to contribute to the development efforts for an exciting new generation of vaccines".

GSK's Chief Executive Andrew Witty said earlier this year he had a "very low appetite" for acquisitions but, like many rivals in the industry, his company is constantly looking for bolt-on transactions to boost its pharmaceuticals, vaccines and consumer healthcare operations.

Last November, for example, GSK agreed to spend $1 billion to raise the stakes it holds in Indian and Nigerian consumer healthcare subsidiaries.

Smaller British rival AstraZeneca has a more urgent need for acquisitions, given its thin pipeline of new medicines to replace those losing patent protection. It agreed on Tuesday to pay up to $443 million for Omthera Pharmaceuticals, a U.S.-based specialist in fish oil-derived medicine.

Okairos's venture capital investors include BioMedInvest, the Boehringer Ingelheim Venture Fund, LSP, Novartis Venture Funds and Versant Ventures.

($1 = 0.7779 euros)

Source: http://news.yahoo.com/gsk-bets-chimp-virus-321-million-vaccines-buy-145459050.html

indiana autoimmune disease news channel 9 insanity workout mass effect 3 launch trailer yelp huntsville al